• 1
    Wershil B. Role of mast cells and basophils in gastrointestinal inflammation. In: Marone G, ed. Chemical Immunology, Vol. 62: Human Basophils and Mast Cells: Clinical Aspects. Basel: Karger, 1995: 187–203.
  • 2
    Fox CC, Lazenburg AJ, Moore WC, et al.Enhancement of human intestinal mast cell mediator release in active ulcerative colitis. Gastroenterology 1990; 99: 11924.
  • 3
    Bischoff SC, Lorentz A, Schwengberg S, Weier G, Raab R, Manns MP. Mast cells are an important cellular source of tumour necrosis factor in human intestinal tissue. Gut 1999; 44: 64352.
  • 4
    Murray M, Jarrett WFN, Jennings FW. Mast cells and macromolecular leak in intestinal immunological reactions. Immunology 1971; 21: 1731.
  • 5
    Deusch K, Reich K. Immunological aspects of inflammatory bowel disease. Endoscopy 1992; 24: 56877.
  • 6
    Cairns JA, Walls AF. Mast cell tryptase is a mitogen for epithelial cells: stimulation of IL-8 production and ICAM-1 expression. J Immunol 1996; 156: 27583.
  • 7
    Sutherland LR, Martin F, Greer S, et al.5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis and proctitis. Gastroenterology 1987; 92: 18948.
  • 8
    Irani AA, Schecter NM, Craig SS, et al.Two human mast cell subsets with distinct protease composition. Proc Natl Acad Sci USA 1986; 83: 44648.
  • 9
    Fox CC, Dvorak AM, Peters SP, et al.Isolation and characterization of human intestinal mucosal mast cells. J Immunol 1985; 135: 48391.
  • 10
    Bischoff SC, Lorentz A, Schwengberg S, et al.Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue. Gut 1999; 44(5): 64352.
  • 11
    Murch SH, Braegger CP, Walker-Smith JA, et al.Location of tumour necrosis factor α by immunohistochemistry in chronic inflammatory bowel disease. Gut 1993; 34: 17059.
  • 12
    Reinecker HC, Steffen M, Witthoeft T, et al.Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993; 94: 17481.
  • 13
    Fox CC, Moore WC, Lichtenstein LM. Modulation of mediator release from human intestinal mast cells by sulfasalazine and 5-aminosalicylic acid. Dig Dis Sci 1991; 36: 17984.
  • 14
    Goldsmith P, McGarity B, Walls AF, et al.Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease. Dig Dis Sci 1990; 35: 140913.
  • 15
    McMenamin C, Gault E, Haif D. The effect of dexamethasone on growth and differentiation of bone marrow-derived mucosal mast cells in vitro. Immunology 1987; 62: 2934.
  • 16
    Soda K, Kawabori S, Perdue M, et al.Macrophage engulfment of mucosa mast cells in rats treated with dexamethasone. Gastroenterology 1991; 100: 92937.
  • 17
    Butterfield J, Weider D. In vitro sensitivity of immature mast cells to chemotherapeutic agents. Int Arch Allergy Appl Immunol 1989; 89: 297300.